Hungary's Richter sees weak home market for years
Hungarian drug manufacturer Richter Gedeon expects its domestic market to remain sluggish for years, Chief Executive Erik Bogsch told business daily Világgazdaság.
Bogsch said he sees little chance to reverse the negative trends which have hampered growth in Hungary and as a result the share of domestic sales as part of overall revenue will continue to shrink, Bogsch said.
He added that Hungary is an exception in a fast-growing Central and East European region and the company expects fast growth in Russia, Poland and Romania to fuel its top line growth.
Hungary's drug market has suffered over the past two years due to government measures to curb budget expenditures in its effort to cut what is the European Union's biggest national budget deficit.
The government has cut subsidies, raised prices, increased taxes and implemented new fees to restrict drug sales. (Reuters)
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.